Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) | Present Value of Free Cash Flow to the Firm (FCFF)

Valuation of Regeneron common stock using free cash flow to the firm (FCFF) model, which belongs to discounted cash flow (DCF) approach of intrinsic stock value estimation.

采用企业自由现金流（FCFF）模型对Regeneron普通股进行估值，该模型属于内在股票价值估算的折现现金流（DCF）方法。